Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany.

导出 LinkOut

翻译打印收藏纠错

第一作者： Peter,Dall

第一单位： Department of Obstetrics and Gynaecology and Breast Cancer Center, Klinikum Lüneburg, Lüneburg, Germany. Electronic address: peter.dall@klinikum-lueneburg.de.

作者： Peter,Dall ^[1] ; Gertrud,Lenzen ^[2] ; Thomas,Göhler ^[3] ; Christian,Lerchenmüller ^[4] ; Gabriele,Feisel-Schwickardi ^[5] ; Thorsten,Koch ^[6] ; Jochen,Eggert ^[7] ; Volker,Heilmann ^[8] ; Christof,Schindler ^[9] ; Jochen,Wilke ^[10] ; Hans,Tesch ^[11] ; Johannes,Selbach ^[12] ; Tim,Wohlfarth ^[13] ; Heidi,Eustermann ^[14] ; Axel,Hinke ^[14]

作者单位： Department of Obstetrics and Gynaecology and Breast Cancer Center, Klinikum Lüneburg, Lüneburg, Germany. Electronic address: peter.dall@klinikum-lueneburg.de. ^[1] Oncology Practice, Osnabrück, Germany. ^[2] Onkozentrum Dresden/Freiberg, Dresden, Germany. ^[3] Oncology Practice, Münster, Germany. ^[4] Department of Obstetrics and Gynaecology and Breast Cancer Center, Klinikum Kassel, Kassel, Germany. ^[5] Breast Center, Klinikum Nürnberg, Nürnberg, Germany. ^[6] Oncology Practice, Moers, Germany. ^[7] Oncology Practice, Günzburg, Germany. ^[8] Gynecology Practice, Leipzig, Germany. ^[9] Oncology Practice, Fürth, Germany. ^[10] Onkologie Bethanien, Frankfurt, Germany. ^[11] Oncology Practice, Duisburg, Germany. ^[12] Roche Pharma AG, Grenzach-Wyhlen, Germany. ^[13] WiSP Research Institute, Langenfeld, Germany. ^[14]

关键词 Early breast cancer Elderly patients Her2 overexpression Non-interventional study Trastuzumab